Hahn E A, Webster K A, Cella D, Fairclough D L
Center on Outcomes, Research and Education, Evanston Northwestern Healthcare, IL 60201, USA.
Stat Med. 1998;17(5-7):547-59. doi: 10.1002/(sici)1097-0258(19980315/15)17:5/7<547::aid-sim802>3.0.co;2-f.
Incorporation of quality of life (QOL) investigation into Eastern Cooperative Oncology Group (ECOG) multi-centre clinical trials has led to innovative strategies for protocol design and high quality data collection. A scientific advisory committee reviews protocol design components, measurement selection, timing of assessments and compliance issues. Extensive educational programmes provide information about the scientific and clinical relevance of QOL protocols, as well as practical strategies for data collection and management. Compliance with QOL data collection standards is prospectively monitored and evaluated. Preliminary results from eight ECOG-run protocols found overall compliance to be approximately 85 per cent (94 per cent at baseline and 73 per cent during treatment). Selected patient and institutional factors were evaluated for their association with compliance.
将生活质量(QOL)调查纳入东部肿瘤协作组(ECOG)的多中心临床试验,促成了方案设计和高质量数据收集的创新策略。一个科学咨询委员会会审查方案设计组成部分、测量方法选择、评估时间安排和合规性问题。广泛的教育计划提供有关QOL方案的科学及临床相关性的信息,以及数据收集和管理的实用策略。对QOL数据收集标准的遵守情况进行前瞻性监测和评估。ECOG执行的八项方案的初步结果显示,总体合规率约为85%(基线时为94%,治疗期间为73%)。对选定的患者和机构因素与合规性的关联进行了评估。